Recent analyst upgrades for Axon Enterprise (AXON) are putting fresh focus on the company following record quarterly revenue of US$807 million and increased use of its AI-driven public safety tools.
See our latest analysis for Axon Enterprise.
Axon Enterprise’s recent analyst upgrades and contract headlines come after a strong run in the stock, with a 30 day share price return of 28.62% and a 90 day share price return of 68.24%, even as the 1 year total shareholder return declined 20.60%.
If Axon’s AI driven tools have caught your attention, it can be useful to compare it with other fast growing players by reviewing 63 profitable AI stocks that aren't just burning cash
After Axon Enterprise’s sharp move, some investors will be tempted to chase momentum while others wait for a pullback. To weigh those choices, it helps to look at what the current valuation already reflects.
Most Popular Narrative: 4.1% Undervalued
Axon Enterprise’s most followed narrative sees fair value at $606.83 per share versus the last close of $582.00, putting the stock slightly below that reference point and centering the debate on how durable its public safety platform could be.
One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.
Curious what sits behind that fair value for Axon Enterprise? According to AryaWinningSon, the story leans heavily on recurring software revenue, richer margins and a valuation framework that treats Axon more like a specialised public safety platform than a hardware vendor.
Result: Fair Value of $606.83 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Axon Enterprise’s story could be challenged if public sector budgets tighten or if agencies push back on AI driven tools and long term software contracts.
Find out about the key risks to this Axon Enterprise narrative.
Another View on Axon Enterprise’s Valuation
The most popular Axon Enterprise narrative leans on a fair value of $606.83 per share, but the market multiples tell a sharper story. The stock trades on a P/S of 15.7x versus 5.3x for the US Aerospace & Defense industry and 7.1x for peers, while the fair ratio is 17.1x.
This means Axon Enterprise sits at a heavy premium to its sector and peers, yet still slightly below the fair ratio the market could move toward. This leaves investors weighing valuation risk against the possibility that the stock simply stays expensive for longer. Which side of that tradeoff fits your approach?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mix of excitement and concern around Axon Enterprise, this is a good moment to act quickly, review the underlying data, and decide where you stand using the full picture of 1 key reward and 3 important warning signs.
Looking for more investment ideas beyond Axon Enterprise?
If Axon Enterprise has sharpened your focus on quality, do not stop here. Broaden your watchlist with ideas that fit different risk, income, and value goals.
- Target potential mispricing by scanning 44 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their underlying strength.
- Build a steadier income stream by reviewing 9 dividend fortresses offering higher yields that could complement growth oriented holdings like Axon Enterprise.
- Protect your portfolio’s downside by researching 73 resilient stocks with low risk scores that score well on resilience and financial robustness before the crowd catches on.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com